{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:58:30Z","timestamp":1777661910691,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.ahj.2003.09.013","type":"journal-article","created":{"date-parts":[[2004,2,3]],"date-time":"2004-02-03T05:09:03Z","timestamp":1075784943000},"page":"239-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study"],"prefix":"10.1016","volume":"147","author":[{"given":"Lidia","family":"Arcavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon","family":"Behar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avraham","family":"Caspi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naama","family":"Reshef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Boyko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilla","family":"Knobler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2003.09.013_BIB1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/bmj.308.6940.1323","article-title":"Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes","volume":"308","author":"McCane","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2003.09.013_BIB2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/diacare.20.5.785","article-title":"Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes","volume":"20","author":"Engelgau","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2003.09.013_BIB3","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2003.09.013_BIB4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2337\/diacare.21.3.360","article-title":"High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men","volume":"21","author":"Balkau","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2003.09.013_BIB5","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1001\/jama.1990.03440210043030","article-title":"Cardiovascular risk factors in the confirmed prediabetic individuals","volume":"263","author":"Haffner","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2003.09.013_BIB6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.CIR.101.9.975","article-title":"Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects","volume":"101","author":"Haffner","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.09.013_BIB7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.CIR.102.1.21","article-title":"Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease","volume":"102","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.09.013_BIB8","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/0002-9149(93)90905-R","article-title":"Rationale and design of secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease","volume":"71","author":"Goldbourt","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2003.09.013_BIB9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/0895-4356(88)90118-7","article-title":"Diabetes mellitus and arteriographically documented coronary artery disease","volume":"41","author":"Freedman","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ahj.2003.09.013_BIB10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0002-8703(98)70072-9","article-title":"Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease","volume":"135","author":"Barzilay","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2003.09.013_BIB11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/0026-0495(95)90099-3","article-title":"Patients undergoing coronary artery bypass graft surgery are at increased risk of impaired glucose tolerance and diabetes mellitus during the first postoperative year","volume":"44","author":"Farrer","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/j.ahj.2003.09.013_BIB12","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-9149(00)80059-4","article-title":"Relation of angiographically defined coronary artery disease and plasma concentrations of insulin, lipid, and apolipoprotein in normolipidemic subjects with varying degrees of glucose tolerance","volume":"75","author":"Fujiwara","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2003.09.013_BIB13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2337\/diacare.24.5.897","article-title":"Disturbances of glucose metabolism in men referred for coronary arteriography","volume":"24","author":"Kowalska","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2003.09.013_BIB14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","article-title":"The relationship between glucose and incident cardiovascular events","volume":"22","author":"Coutinho","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2003.09.013_BIB15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(98)12030-5","article-title":"cardiovascular disease in older adults with glucose disorders","volume":"354","author":"Barzilay","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2003.09.013_BIB16","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)12131-1","article-title":"Glucose tolerance and mortality","volume":"354","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2003.09.013_BIB17","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.22.6.920","article-title":"Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose","volume":"22","author":"Tominaga","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2003.09.013_BIB18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1067\/mhj.2001.113219","article-title":"Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease","volume":"141","author":"Fishman","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2003.09.013_BIB19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0021-9150(99)00217-8","article-title":"Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study","volume":"148","author":"Forrest","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ahj.2003.09.013_BIB20","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","article-title":"Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus","volume":"316","author":"Turner","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2003.09.013_BIB21","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2003.09.013_BIB22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ahj.2003.09.013_BIB23","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2337\/diacare.15.7.820","article-title":"Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study","volume":"15","author":"Koskinen","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2003.09.013_BIB24","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-density Lipoprotein Cholesterol Intervention Trial Study Group","volume":"341","author":"Rubins","year":"1999","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ahj.2003.09.013_BIB25","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(00)04209-4","article-title":"Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes","volume":"357","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2003.09.013_BIB26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/diacare.20.4.614","article-title":"Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease","volume":"20","author":"Pyorala","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2003.09.013_BIB27","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.CIR.98.23.2513","article-title":"Cardiovascular events and their reduction with pravastatin in diabetic infarction survivors with average cholesterol levels","volume":"98","author":"Goldberg","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2003.09.013_BIB28","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1016\/j.ahj.2003.09.013_BIB29","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1001\/archinte.159.22.2661","article-title":"Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels","volume":"159","author":"Haffner","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2003.09.013_BIB30","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.2337\/diacare.26.2007.S83","article-title":"Management of dyslipidemia in adults with diabetes","volume":"26","year":"2003","journal-title":"Diabetes Care"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870303006549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870303006549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:01:13Z","timestamp":1757566873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870303006549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0002870303006549"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2003.09.013","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High fasting glucose levels as a predictor of worse clinical outcome in patients with coronary artery disease: results from the Bezafibrate Infarction Prevention (BIP) study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2003.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}